BE-23372M, a novel protein tyrosine kinase inhibitor. I. Producing organism, fermentation, isolation and biological activities.
BE-23372M, a novel protein tyrosine kinase inhibitor, was isolated from the culture broth of a fungus. The producing strain, F23372, was identified as Rhizoctonia solani, based on the cultural and morphological characteristics. The active principle was extracted from the mycelium with acetone and purified by solvent extraction, silica gel column chromatography and Sephadex LH-20 column chromatography. BE-23372M showed strong inhibitory activity against EGF receptor kinase with IC50 values of 0.02 and 0.03 microM on two different substrates, whereas IC50 values against protein kinase C and cAMP-dependent protein kinase were 4.5 and > 20 microM, respectively. The compound inhibited the growth of A431 human epidermoid carcinoma and MKN-7 human stomach cancer cell lines with IC50 values of 8 and 24 microM, respectively.
Okabe
T
T
Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd., Japan.
Yoshida
E
E
Chieda
S
S
Endo
K
K
Kamiya
S
S
Osada
K
K
Tanaka
S
S
Okura
A
A
Suda
H
H
D000595:Amino Acid Sequence; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002455:Cell Division / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D005285:Fermentation; D005663:Furans / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D008969:Molecular Sequence Data; D010636:Phenols / Q000302:isolation & purification / Q000378:metabolism / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D012232:Rhizoctonia / Q000378:metabolism; D013274:Stomach Neoplasms / Q000188:drug therapy; D014407:Tumor Cells, Cultured
D005663:Furans; D010636:Phenols; C087122:BE 23372M; D011505:Protein-Tyrosine Kinases